Global Onchocerciasis Network for Elimination (GONE)
A man who suffers from onchocerciasis at the Masongbo health center in the town of Masongbo, Sierra Leone.
About us
The Global Onchocerciasis Network for Elimination (GONE) drives a global partnership platform supporting countries to reach the global targets for elimination of onchocerciasis for 2030 set in the WHO road map for neglected tropical diseases.
The GONE network is open to all onchocerciasis stakeholders with demonstrated commitment to working towards the 2030 road map targets for onchocerciasis elimination.
/gone-logo-whitebg.png?sfvrsn=c33f2656_3 "gone-logo-whitebg"){kind=logo}
- To be inclusive and diverse in membership and structure, ensuring adequate representation from different stakeholder groups and geographical regions;
- To be transparent in all processes, including the operational strategy and GONE activities;
- To ensure all activities align with WHO’s norms and standards;
- To facilitate coordination among interested parties to advance WHO’s priorities on the road map 2030.
Main objectives
- To provide an inclusive and open access forum to improve communication, coordination, partnership and community of practice for all onchocerciasis stakeholders working closely to reach the 2030 road map targets for elimination of onchocerciasis.
- To conduct action oriented and effective advocacy working towards the 2030 road nap targets and milestones for onchocerciasis elimination.
Vision
To SEE onchocerciasis GONE!
Mission
To accelerate progress towards the achievement of the 2030 road map targets for onchocerciasis elimination.
Road map targets for onchocerciasis
The road map targets for the elimination of onchocerciasis are, by 2030: to stop mass drug administration (MDA) of ivermectin in at least one focus in 34 countries; to stop MDA in more than 50% of the population in at least 16 countries; to stop MDA in the entire endemic population of at least 12 countries; and to verify interruption of transmission in 12 countries.
Related publication
Ending the neglect to attain the Sustainable Development Goals: A road map for neglected...
Progress of onchocerciasis status worldwide
/progress-onchocerciasis-status-worldwide.tmb-549v.jpg?sfvrsn=47aa747c_4)
/gone-the-new-global-onchocerciasis-network-for-elimination-guinee-the-national-champions-thumbnail.tmb-549v.png?sfvrsn=fb3676f7_1)
/gone-the-new-global-onchocerciasis-network-for-elimination-thumbnail.tmb-549v.jpg?sfvrsn=889f232f_1)
How we work
Launched in January 2023 by WHO, Member States and partners, GONE is a country driven network that brings together diverse stakeholders in order to improve communication, coordination and collaboration and accelerate progress towards onchocerciasis elimination.
Steering Group
The Steering Group provides strategic direction and guidance for how GONE will operate, mobilize collaboration and secure resources to accomplish GONE’s activities. It reviews annual priorities and monitors and evaluates activities to optimize GONE’s functioning and impact.
The Steering Group consists of a Chair (WHO), two Vice-chairs (at least one from an onchocerciasis-endemic country), donors and implementing partners, a representation of key constituencies. Vice-chairs will be confirmed by WHO for a period of two years after consultation with the GONE network participants who can make recommendations for Vice-chair positions. The Chair and Vice-chairs will define annual priorities, support and oversee their timely implementation, and liaise with relevant stakeholders to ensure prompt communication and effective problem-solving.
Operational office
WHO serves as the Secretariat of GONE which leads, manages and implements GONE’s day-to-day operations.
Working groups (WGs)
WGs will be created as required to leverage country and partner expertise and to execute activities around specific objectives in the partnership strategy and operational plan.
Member organizations of GONE
More
than 80 organizations, including health ministries of endemic countries,
non-governmental organizations, research institutes and foundations, have
joined the GONE network to date engaging in a range of network activities
contributing to GONE’s objectives.
Join us/membership
If
your organization is interested in learning more about becoming a member
organization of GONE or if you want to join the GONE network as an individual,
please contact us at rozendaaln@who.int.
Resources and news
WHO publications
All →
WHO Onchocerciasis Technical Advisory Subgroup: report of the eighth meeting, Toledo, Spain, 9–12 December...
The eighth meeting of the WHO Onchocerciasis Technical Advisory Subgroup (OTS) was held on 9–12 December 2024 in Toledo, Spain. The meeting commenced...
WHO Onchocerciasis Technical Advisory Subgroup: report of the seventh meeting, Saly, Senegal, 4 November...
The seventh meeting of the World Health Organization Onchocerciasis Technical Advisory Subgroup (OTS) was held on 4 November 2023 at the Palm Beach...
External publications
- HISTONCHO: A database of intervention histories for onchocerciasis control & elimination in sub-Saharan Africa
medRxiv, 22 May 2025 - Reaching elimination of onchocerciasis transmission with Long-term vector control and Ivermectin treatment in West Africa: the example of Togo
Research Square, 6 April 2025 - Niger eliminates onchocerciasis
- The Lancet Infectious Diseases, volume 25, Issue 4, April 2025
- GONE to combat onchocerciasis
The Lancet Microbe Volume 5, Issue 4, E 413 | 4 April 2024 - Loiasis: bringing an end to neglect
Lancet World Report, 3 October 2024 - A new key-player for onchocerciasis elimination
The Lancet Infectious Diseases Volume 23, Issue 4, Page 413 | 4 April 2023
Work in progress
- Onchocerciasis Technical Subgroup : report of the 8th Meeting, Toledo, Spain 8th to 12th December 2024
- A
practical guide for National Onchocerciasis Elimination Committees
- A mapping
and treatment strategy for Onchocerciasis in Loa coendemic settings
- Integrating
the assessment of onchocerciasis into a lymphatic filariasis transmission
assessment survey (iTAS): A manual for national elimination programmes
- Moxidectin
guidelines for Onchocerciasis and LF treatment
- Integrated
PVS planning toolkit
Latest news
All →Feature story
About Onchocerciasis
Events
All →Other related events
Webinar reports
All →/gone-webinar-strengthening-health-systems-through-ntd-integration-country-experiences-and-innovative-approaches.tmb-144v.png?sfvrsn=4fe8ba86_1)
The webinar highlighted the strategic value of integrating NTD interventions into broader health systems. Countries like Benin, Kenya, Rwanda, and Madagascar...
/webinar-report-covers/gone-webinar-report-malawi-thumbnail.tmb-144v.png?sfvrsn=5b1bf6e8_1)
The Malawi Onchocerciasis Control Programme began in 1984 in collaboration with the Tea Association of Malawi, initially focusing on assessing disease prevalence,...
Country webinars
All →/vector-control-technicians-collect-black-flies-in-senegal.tmb-549v.jpg?sfvrsn=a30ff5ee_1)
/gone-webinar-strengthening-health-systems-through-ntd-integration-8-july-2025.tmb-549v.png?sfvrsn=8699412_1)
Cross-border collaboration
According to the 2016 WHO guidelines for stopping MDA and verification of elimination of onchocerciasis, acknowledgment of elimination requires that areas immediately surrounding a country have interrupted transmission. Efficient and active cross-border coordination is required to achieve elimination targets and to prevent recrudescence where interruption of transmission has been achieved.
Enhancing cross-border collaboration is one of the priority areas of the GONE network. Endemic areas that contain national borders present an important challenge to the success of elimination of onchocerciasis and require unification of programme activities. The effectiveness of cross-border collaboration can be hindered by issues such as inadequate financial resources, logistical challenges for synchronizing elimination strategies, language barriers, insecurity, conflict, and population mobility.
High-level advocacy to establish collaboration agreements between countries, resource mobilization to support cross-border activities, data collection and sharing have been identified as priorities. Synchronization of MDA, inclusion of cross-border collaboration activities in the meeting agendas of the Onchocerciasis Elimination Committee and the empowerment of local district working groups have also been identified as important factors for improving cross-border collaboration. National onchocerciasis elimination programmes collaborate to ensure that no one is left behind.
GONE is collaborating with Sightsavers who have created an open-access geospatial application called CrossRoads to support Ministries of Health and implementing partners with cross-border geographic data review. GONE is gathering cross-border data and facilitating trainings on the application. More country group applications will be finalized over the coming months.
At this website you can find more information on CrossRoads.
On 21 May 2025, GONE in collaboration with the African Union Commission, The END fund and Drugs for Neglected Diseases initiative (DNDi) organized a high-level side event themed “Accelerating NTD elimination through country-driven efforts and cross-border collaboration,” held on the margins of the 78th World Health Assembly.
Global Health leaders of Cameroon, Niger and Nigeria launched a Call for Action inviting other Member States to also endorse the Call. This initiative aims to strengthen cross-border collaboration against NTDs by coordinating efforts and endorsing joint Memoranda of Understanding (MoUs) to facilitate synchronized interventions, surveillance, and data sharing across borders. For more information and for endorsing the Call for Action, contact the GONE Secretariat at rozendaaln@who.int.
National onchocerciasis elimination committees (NOECs)
National onchocerciasis elimination committees (NOECs) serve to help ministries of health complete the pathway to successful verification of elimination of onchocerciasis, as outlined in the 2016 World Health Organization guidelines for stopping mass drug administration and verifying elimination of human onchocerciasis.